GILD missed the boat on Leronlimab. They needed t

Quote:

---

GILD missed the boat on Leronlimab. They needed to protect their HIV franchise and that went out the window with the Vyera deal.

---

They are definitely screwed. We have Leron, the SERIAL Indication solution, and Skherli on our side. CYDY would be the next GILD...

Also, there was some comments about seeing .9 today or not.
It doesn't really matter what Fall or any other people say. If you notice even he doesn't keep short over night, and everytime it drops he comes and throws a bunch or messages so his follower think he knows something, and also he can cover his short by throwing them under the truck.
It doesn't really matter what the price will be today, tomorrow or any other day. We have so many catalyst to shoot us through the roof. in the next 2 months alone. BLA, NASH licensing, BTD to name a few. We are least 3 times more in 2 months, IMO.

Happy investing and GLTA

If you ask me, I'll only say, load up boys.
All, IMO